Standard and Interpretation
Recommendations on the diagnosis and treatment of osteoarthritis in China
Zhao Yanping, Lin Zhiguo, Lin Shudian, Xia Liping, Zhang Zhiyi, Zhao Yan, on behalf of Chinese Rheumatology Association
Published 2022-10-01
Cite as Chin J Intern Med, 2022, 61(10): 1136-1143. DOI: 10.3760/cma.j.cn112138-20220416-00280
Abstract
Osteoarthritis (OA) is the most common form of arthritis and the leading cause of old age disability, affecting an estimated 302 million people worldwide. OA is seriously overlooked in the world. The awareness of OA and the popularization of standardized diagnosis and treatment are all lacking. Knees, hips, and hands are the most commonly affected joints in OA. Based on the experience of diagnosis and treatment, consensus and guidelines, we formulated this diagnosis and treatment standard in order to standardize the diagnosis and treatment of OA. We hope that our standard can reduce misdiagnosis and mistreatment and improve the prognosis of OA.
Key words:
Osteoarthritis; Diagnosis; Treatment; Prognosis
Contributor Information
Zhao Yanping
Department of Rheumatology and Immunology, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
Lin Zhiguo
Department of Rheumatology and Immunology, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
Lin Shudian
Department of Rheumatology and Immunology, Hainan General Hospital, Haikou 570311, China
Xia Liping
Department of Rheumatology and Immunology, the First Hospital of China Medical University, Shenyang 110001, China
Zhang Zhiyi
Department of Rheumatology and Immunology, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
Zhao Yan
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science &
Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
on behalf of Chinese Rheumatology Association
